CHALLENGES FOR ASSESSING THE ECONOMIC VALUE OF ORPHAN DRUGS - A LITERATURE REVIEW OF CURRENT AND ALTERNATIVE APPROACHES

被引：4
|
作者：
Cote, S. [1 ]
Gaudig, M.
Nielsen, S. K. [2 ,3 ]
Shields, G. E. [4 ]
Britton, J. A. [4 ]
机构：
[1] Janssen Cilag, High Wycombe, Bucks, England
[2] Janssen Hlth Econ & Market Access EMEA, Neuss, Germany
[3] BresMed, Panaji, India
[4] BresMed, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2026
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY126
引用
收藏
页码：A681 / A681
页数：1
相关论文
共 50 条
  • [1] Assessing the economic challenges posed by orphan drugs
    Drummond, Michael F.
    Wilson, David A.
    Kanavos, Panos
    Ubel, Peter
    Rovira, Joan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 36 - 42
  • [2] Assessing the economic challenges posed by orphan drugs: A response to McCabe et al.
    Drummond, Michael F.
    Wilson, David A.
    Kanavos, Panos
    Ubel, Peter A.
    Rovira, Joan
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (03) : 401 - 404
  • [3] Assessing the economic challenges posed by orphan drugs: A comment on Drummond et al.
    McCabe, Christopher
    Tsuchiya, Aki
    Claxton, Karl
    Raftery, James
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (03) : 397 - 401
  • [4] Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review
    Grand, Tobias Sydendal
    Ren, Shijie
    Hall, James
    Astrom, Daniel Oudin
    Regnier, Stephane
    Thokala, Praveen
    PHARMACOECONOMICS, 2024, 42 (06) : 619 - 631
  • [5] Assessing the regional economic development impacts of universities: A review of current approaches
    Encina Morales de Vega, Maria
    REVISTA ESPANOLA DE PEDAGOGIA, 2014, 72 (257): : 194 - 195
  • [6] Assessing the regional economic development impacts of universities: A review of current approaches
    Drucker, Joshua
    Goldstein, Harvey
    INTERNATIONAL REGIONAL SCIENCE REVIEW, 2007, 30 (01) : 20 - 46
  • [7] How to Value Orphan Drugs? A Review of European Value Assessment Frameworks
    Blonda, Alessandra
    Denier, Yvonne
    Huys, Isabelle
    Simoens, Steven
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] OF RARE DISEASES AND ORPHAN DRUGS: A REVIEW OF CURRENT NEUROSCIENCE
    Polanco-Carrasco, Roberto
    PSIENCIA-REVISTA LATINOAMERICANA DE CIENCIA PSICOLOGICA, 2010, 2 (01): : 8 - 14
  • [9] SYSTEMATIC LITERATURE REVIEW OF TRADITIONAL AND NON-TRADITIONAL VALUE CRITERIA USED TO EVALUATE ORPHAN DRUGS
    Zelei, T.
    Mendola, N.
    Elezbawy, B.
    Campbell, J. D.
    VALUE IN HEALTH, 2020, 23 : S339 - S339
  • [10] Alternative and in vitro approaches: Current perspective and future challenges
    Kimber, I
    TOXICOLOGY, 2004, 202 (1-2) : 43 - 44
12345